Shares of Metis TechBio jumped 185% during its Wednesday debut on the Hong Kong exchange. The firm uses artificial intelligence to optimize drug delivery and formulation. This spike follows a trend of volatile first-day gains for biotech listings. Investors now watch if the company can translate this initial market enthusiasm into sustainable clinical results.